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Activation of the endothelin system and vaso-
constriction has been reported in animal mod-
els (Bouthillier et al. 1998; Kang et al. 2002;
Thomson et al. 2004, 2005; Vincent et al.
2001a) and humans (Brook et al. 2002;
Calderón-Garcidueñas et al. 2005; Vincent
et al. 2001b) after exposure to air pollutants.
Endothelin-1 (ET-1) is implicated directly in
the progression of cardiovascular diseases
(Luscher and Barton 2000), and a number of
polymorphisms for ET-1 and endothelin recep-
tor genes have been identiﬁed that are associ-
ated with increased risk for pulmonary and
cardiovascular conditions (Charron et al. 1999;
Dong et al. 2004; Immervoll et al. 2001; Jin
et al. 2003). ET-1 is atherogenic (Ihling et al.
2001; Lerman et al. 1995), and exposure to air
pollutants has been shown to accelerate athero-
sclerosis in animals (Sun et al. 2005; Suwa et al.
2002) and humans (Künzli et al. 2005).
Therefore, recurrent or sustained elevation of
circulating ET-1 constitutes a plausible cause of
some acute and chronic adverse health effects of
air pollutants (Thomson et al. 2005).
The ambient atmosphere in Mexico City
is characterized by elevated concentrations of
ozone (especially in the southwest), and par-
ticulate matter (in the northeast), that fre-
quently exceed United States air quality
standards. Particulate matter (PM) is catego-
rized by aerodynamic diameter into three
classes: coarse PM 2.5–10 µm in aerodynamic
diameter (PM10), fine PM 0.1–2.5 µm in
aerodynamic diameter (PM2.5), and ultraﬁne
PM < 0.1 µm in aerodynamic diameter. In
addition to particulate matter and O3, alde-
hydes, volatile and nonmethane organic
compounds, alkane hydrocarbons, and
lipopolysaccharide (LPS) (15.3–20.6 ng/mg)
are other typical contaminants of ambient
Mexico City air (Bonner et al. 1998). Because
of moderate climatic conditions, children in
Mexico City engage in play and outdoor
physical activities throughout the year in the
late morning and afternoon when the diurnal
pollutant levels are at their maximum
(Villarreal-Calderón et al. 2002). Exposure to
such contaminated air may pose a signiﬁcant
health risk for children.
Clinically healthy children residing in
Mexico City exhibit pulmonary hyperinfla-
tion and interstitial markings on chest X rays
(Calderón-Garcidueñas et al. 2006), and an
imbalance of serum cytokines with signifi-
cantly increased concentrations of interleukin
(IL)-6 and IL-10 compared with children
residing in areas with low levels of pollution
(Calderón-Garcidueñas et al. 2003). In the
study reported here, we investigated the
plasma concentrations of ET-1 in Mexico
City children and children from a control city
with low levels of air pollutants. Because
pediatric radiologists have noticed prominent
pulmonary arteries in anterior–posterior chest
X rays of Mexico City children, and given
that ET-1 regulates pulmonary arterial pres-
sure (PAP), our secondary objective was to
determine whether these children have
increased PAP. Our third objective was to
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BACKGROUND: Controlled exposures of animals and humans to particulate matter (PM) or ozone
air pollution cause an increase in plasma levels of endothelin-1, a potent vasoconstrictor that regu-
lates pulmonary arterial pressure.
OBJECTIVES: The primary objective of this ﬁeld study was to determine whether Mexico City chil-
dren, who are chronically exposed to levels of PM and O3 that exceed the United States air quality
standards, have elevated plasma endothelin-1 levels and pulmonary arterial pressures. 
METHODS: We conducted a study of 81 children, 7.9 ± 1.3 years of age, lifelong residents of either
northeast (n = 19) or southwest (n = 40) Mexico City or Polotitlán (n = 22), a control city with PM
and O3 levels below the U.S. air quality standards. Clinical histories, physical examinations, and
complete blood counts were done. Plasma endothelin-1 concentrations were determined by
immunoassay, and pulmonary arterial pressures were measured by Doppler echocardiography. 
RESULTS: Mexico City children had higher plasma endothelin-1 concentrations compared with con-
trols (p < 0.001). Mean pulmonary arterial pressure was elevated in children from both northeast
(p < 0.001) and southwest (p < 0.05) Mexico City compared with controls. Endothelin-1 levels in
Mexico City children were positively correlated with daily outdoor hours (p = 0.012), and 7-day
cumulative levels of PM air pollution < 2.5 µm in aerodynamic diameter (PM2.5) before endothe-
lin-1 measurement (p = 0.03). 
CONCLUSIONS: Chronic exposure of children to PM2.5 is associated with increased levels of circulat-
ing endothelin-1 and elevated mean pulmonary arterial pressure.
KEY WORDS: air pollution, endothelial dysfunction, endothelin-1, children, particulate matter, pul-
monary arterial pressure. Environ Health Perspect 115:1248–1253 (2007). doi:10.1289/ehp.9641
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Mexico City children were correlated with
pollutant exposure levels.
Materials and Methods
Study areas and pollutant exposure estimates.
We selected two urban areas, Mexico City
and Polotitlán, for this field study. Mexico
City is located in a high mountain basin
2,250 m above sea level. The control city,
Polotitlán, is located in the Mexico State
114 km northwest of Mexico City at 2,380 m
above sea level. Mexico City residents are
chronically exposed to concentrations of crite-
ria air pollutants that exceed the United States
standards, whereas air pollutant levels rarely
exceed the standards in Polotitlán. Criteria air
pollutants were monitored in Mexico City by
the government atmospheric monitoring sys-
tem at four stations: two in the southwest
(Pedregal and Coyoacán) and two in the
northeast (Xalostoc and San Agustín). Each
child’s residence and school was within
5 miles of one of these monitoring stations.
The pollutants that consistently exceeded
their respective standard in the preceding
5 years were O3, PM10, and PM2.5. Thus, for
these pollutants we estimated the cumulative
exposure levels for each child for 1, 2, and
7 days before the measurement of plasma
ET-1 levels. Pollutant concentrations between
0700 and 1900 hr, when the children were
most active, were used for these estimates. 
Study population. We studied two
cohorts of clinically healthy children, 6–13
years of age: The control cohort from
Polotitlán (n = 22), and the exposed cohort
from Mexico City (n = 59). Mexico City chil-
dren came from two areas, the southwest (n =
40) and the northeast (n = 19), which have
different air pollutant profiles (Raga et al.
2001). All included children were physically
active and regular participants in a variety of
outdoor physical activities. The information
obtained from each child and/or parent (usu-
ally the mother) included age, place and
length of residency, daily outdoor time,
household cooking methods, parents’ occupa-
tional history, family history of atopic ill-
nesses and respiratory disease, and personal
history of otolaryngologic and respiratory
symptoms. The study protocol was approved
by the Human Studies Committee of the
Institutional Review Board of the National
Institute of Pediatrics, Mexico City.
Study protocol. Recruitment (by word of
mouth) was done between July 2003 and
December 2004. The children of parents who
volunteered their participation made at least
four visits to the facility. The ﬁrst visit was a
screening visit. The study inclusion criteria
were nonsmoking household and negative
personal smoking history and environmental
tobacco smoke exposure; lifelong residency in
Mexico City or Polotitlán; residency within
5 miles of air pollutant monitoring stations;
age 6–13 years; full-term birth; no known
exposures to local sources of air pollutants
(e.g., proximity to car-painting shops, gas sta-
tions, factories, solvents, carpenter’ shops,
printing business); unremarkable clinical his-
tories, including negative history of hospital-
izations for respiratory illnesses, negative
personal and family histories of atopic diseases,
no lower respiratory illnesses, febrile episodes,
or vaccinations in the previous 3 months; no
indoor pets; and negative history of frequent
travels outside Mexico City, or to a large city
in the case of control children. Those who
qualiﬁed for the study came for a second visit
to give written consent from the children’s
parents and oral consent from the children
themselves. Once qualiﬁed, they were sched-
uled for subsequent visits, which included a
physical by a pediatrician, fasting blood draw,
and the Doppler echocardiogram exam.
Plasma ET-1 levels and blood tests.
Fasting peripheral blood samples were taken
between 0700 and 0900 hr for complete
blood count with differential and the prepara-
tion of plasma for determination of ET-1 lev-
els. A QuantiGlo ELISA was used for the
determination of ET-1 concentrations in
accordance with the manufacturer’s instruc-
tions (R&D Systems, Inc., Minneapolis, MN,
USA). The mean minimum detectable ET-1
concentration was 0.064 pg/mL.
Doppler echocardiography. Cardiovascular
function was assessed by two-dimensional
(2D), M-mode, and Doppler echocardiogra-
phy. Standard 2D echocardiographic examina-
tions were performed with each child in the
supine left position in accordance with recom-
mendations of the American Society of
Echocardiography (Schiller et al. 1989). The
parents were instructed to avoid caffeine-con-
taining beverages 24 hr before the children’s
examinations. The echocardiographic analysis
was performed with commercially available
ultrasound systems (Sonos 2500; Hewlett–
Packard Co./Agilent Technologies, Andover,
MA, USA) equipped with 2.5- and 3.5-mHz
transducers. Parasternal long- and short-axis
views, as well as apical four- and two-chamber
views, were used for evaluation of the functions
of the ventricles and the heart valves. The pro-
tocol placed highest priority on systolic PAP,
tricuspide, and right ventricle measurements.
Systolic PAP encompasses the pulsatile compo-
nent of arterial load, which includes the charac-
teristics of right ventricular ejection and the
proximal pulmonary arteries and wave reﬂec-
tions (Chemla et al. 2004). We calculated mean
pulmonary arterial pressure (MPAP) from the
systolic pressure using the formula from
Chemla et al. (2004). The MPAP reﬂects the
steady component of ﬂow and the functional
status of the distal pulmonary vasculature
(Chemla et al. 2004). The complete protocol
imaged the morphology of all four cardiac
chambers and valves, and evaluated valve func-
tion and right ventricular outﬂow.
Statistical analyses. The primary variables
of interest were ET-1 concentrations and
MPAP. We performed analysis of variance by
a parametric one-way analysis of variance and
the Newman-Keuls multiple comparison post
test. We calculated correlations between vari-
ables using Pearson’s correlation. We consid-
ered a two-sided type I error rate of 0.05 to be
significant when comparing differences
between group means. Data are expressed as
mean ± SE. All the statistical computations
were performed with the use of Stata 8.3 soft-
ware (StataCorp., College Station, TX, USA)
or GraphPad Prism version 3.3 (GraphPad
Software Inc., San Diego, CA, USA).
Results
Demographics and physical exams. All partici-
pant children were from middle-class families
who lived in single-family houses. No occupa-
tional toxic exposures were reported by par-
ents or close relatives. Children slept in
bedrooms with no carpeting and had open
windows for ventilation. All households had
kitchens separated from the living and sleep-
ing areas and used gas for cooking. A physical
examination performed by the pediatrician
showed that vital signs were unremarkable in
all participant children. Children in this study
had anthropometric values (weight and
height) within normal limits for their age and
sex. The demographic, clinical, and labora-
tory data for the three cohorts are summa-
rized in Table 1. 
Plasma ET-1 levels and pulmonary arter-
ial pressures. Compared with those from con-
trols, mean plasma ET-1 concentrations were
significantly higher in children from both
northeast (p < 0.001; Figure 1, Table 1) and
southwest (p < 0.001; Figure 1, Table 1)
Mexico City as well as for all Mexico City chil-
dren combined (2.24 ± 0.12 pg/mL; p < 0.001,
Figure 1, Table 1). ET-1 levels tended to be
higher in northeastern children than in south-
western children (Figure 1, Table 1), although
the difference was not statistically signiﬁcant.
None of the children had cardiac ana-
tomic abnormalities as assessed by echo-
cardiography. Compared with the control
cohort, the average MPAP, computed from
systolic PAP determined by Doppler echocar-
diography, was significantly elevated in chil-
dren from both northeast (p < 0.01; Figure 2,
Table 1) and southwest (p < 0.05; Figure 2,
Table 1) Mexico City, as well as for all
Mexico City children combined (17.3 ± 0.5
mmHg, p < 0.01; Figure 2, Table 1). As was
the case for ET-1 levels, MPAP tended to be
higher in northeastern children than in south-
western children (Figure 2, Table 1). When
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was a signiﬁcant positive correlation between
MPAP and plasma ET-1 levels (r = 0.43,
p < 0.0001, Figure 3).
Three children in the Mexico City cohort
had MPAPs > 25 mmHg at rest and/or sys-
tolic pressure > 40 mmHg at rest, levels that
are characteristic of pulmonary arterial hyper-
tension (Simonneau et al. 2004). The three
Mexico City children included two 8-year-old
girls, one from the southwest and one from
the northeast, and one 8-year-old boy from
the southwest. All three had elevated plasma
ET-1 (1.8, 1.9, and 2.9 pg/mL, respectively).
Their systolic pressures ranged from 40 to 45
mmHg and their mean pressures ranged from
26 to 29 mmHg. 
White blood cell counts. Children from
northeast Mexico City exhibited significant
decreases in both neutrophil absolute counts
(p < 0.05) and neutrophils as a percentage of
white blood cells (p < 0.01) when compared
with controls (Figure 4A, Table 1). Children
from southwest Mexico City had depressed
neutrophil levels as well (Figure 4A, Table 1),
but the differences between southwest Mexico
City children and control children were not
statistically significant. Even so, all Mexico
City children taken together had statistically
signiﬁcant decreases in circulating neutrophil
concentrations compared with controls (3.0 ±
0.2 × 103/µL, p < 0.05; Figure 4A). The low-
est absolute neutrophil counts recorded were
1.4 × 109/L. No children had neutropenia
deﬁned as < 1 × 109 neutrophils/L.
There was an increase in average lympho-
cyte concentrations in children from north-
eastern Mexico City (p < 0.05) and a smaller
nonsignificant increase in lymphocyte con-
centrations in children from southwestern
Mexico City (Figure 4B, Table 1) compared
with control children. Average monocyte con-
centrations were essentially the same in
Mexico City children (Figure 4C, Table 1)
compared with controls. Average total white
blood cell counts were lower in both north-
eastern and southwestern (Figure 4D, Table
1) Mexico City children, but the differences
were not statistically signiﬁcant. 
Correlation of ET-1 levels with outdoor
hours and pollutant exposure. For Mexico
City children, there was a signiﬁcant, positive
correlation between the number of hours
spent outdoors every day (outdoor hours) and
ET-1 levels (r = 0.31, p = 0.012). Likewise,
there was a significant, positive correlation
between outdoor hours and mean PAP (r =
0.42, p = 0.0008). This supported the notion
that these effects are associated with exposure
to air pollutants. To determine which air pol-
lutants might be involved, we examined the
acute cumulative exposure levels of PM2.5,
PM10, and O3 for each Mexico City subject
over 1, 2, and 7 days preceding the measure-
ment of ET-1 levels. The average PM2.5 expo-
sures for northeast Mexico City children over
the 2- and 7-day cumulative periods preceding
the measurement of ET-1 levels were signiﬁ-
cantly greater than for southwestern children
(Figure 5A). In contrast, the average PM10
exposures were not signiﬁcantly different for
northeastern and southwestern children
(Figure 5B). O3 exposures had a pattern that
was the opposite of PM2.5 exposures. South-
western children were exposed to signiﬁcantly
higher O3 levels than northeastern children
over the 2-day and 7-day periods before ET-1
measurement (Figure 5C). Thus only PM2.5
exposures were greater in northeastern chil-
dren than in southwestern children. This pat-
tern was similar to the pattern of ET-1 levels,
which tended to be higher in the northeast
than in the southwest (Figure 1). When all
Mexico City children were considered, there
was a signiﬁcant, positive correlation between
ET-1 levels and the 7-day cumulative PM2.5
exposure (r = 0.28, p = 0.03).
Discussion
Mexico City is located in a high mountain
basin 2,250 m above sea level. Sunshine, light
winds, temperature inversions, a basin setting,
overcrowded population, heavy traffic, fre-
quent urban leakage of liquefied petroleum
gas, and intense industrial activity promote
complex photochemical reactions producing a
variety of oxidant chemicals and particulate
matter. Because of the subtropical latitude and
high altitude, the high concentrations of pol-
lutants in Mexico City are seen throughout
the year, with only small seasonal variation.
Calderón-Garcidueñas et al.
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Table 1. Demographic, clinical, and laboratory data (mean ± SE) in the control (Polotitlán) and the north-
east (NEMC) and southwest (SWMC) Mexico City cohorts. 
Characteristic Control SWMC NEMC
No. 22 40 19
Age (years) 7.4 ± 0.2 9.0 ± 0.3 7.2 ± 0.3
Sex (male/female) 9/13 20/21 9/10
Plasma ET-1 (pg/mL) 1.23 ± 0.06 2.40 ± 0.14 2.09 ± 0.10
Systolic pulmonary pressure (mmHg) 20.7 ± 0.7 24 ± 0.9 27.2 ± 1.4
Mean pulmonary pressure (mmHg) 14.6 ± 0.4 16.7 ± 0.6 18.6 ± 0.9
Fraction of children with pulmonary arterial pressure > 25 mmHg at rest  0/22  2/40  1/19 
Sex (male/female)  0/0 1/1 0/1
Outdoor exposure time per day (hr) 4.3 ± 0.2 3.9 ± 0.2 4.0 ± 0.2
White blood cells (109/L) 6.9 ± 0.3 6.4 ± 0.3 5.9 ± 0.3
Neutrophils (%) 54.1 ± 1.9 48.8 ± 1.8 44.4 ± 2.2
Neutrophils (109/L) 3.8 ± 0.3 3.2 ± 0.2 2.6 ± 0.2
Lymphocytes (%) 36.4 ± 1.8 40.4 ± 1.7 45.8 ± 2.0
Monocytes (%) 6.9 ± 0.4 6.8 ± 0.3 6.6 ± 0.3
Platelets (109/L) 312 ± 16 304 ± 11 299 ± 20
Hemoglobin (g/dL) 14.0 ± 0.1 14.2 ± 0.1 14.0 ± 0.1
Hematocrit (%) 41.1 ± 0.4 42.7 ± 0.3 41.5 ± 0.6
Figure 1. A scatterplot of plasma ET-1 levels by region.
Mean plasma ET-1 levels for Mexico City children
as a whole (n = 59), as well as for northeast (NEMC,
n = 19) and southwest (SWMC, n = 40) Mexico City
children analyzed separately were significantly
greater than the mean for control (Polotitlán) chil-
dren (n = 22). Horizontal bar indicates group means. 
*p < 0.001.
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Figure 2. A scatterplot of MPAP by region. The
average MPAP for Mexico City children as a whole
(n = 59), as well as for northeast (NEMC, n = 19) and
southwest (SWMC, n = 40) Mexico City children
analyzed separately were signiﬁcantly greater than
the mean for control (Polotitlán) children (n = 22).
Horizontal bar indicates group means. 
*p < 0.01; #p < 0.05.
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Figure 3. A plot of MPAP versus ET-1 levels for
Polotitlán, northeast (NEMC), and southwest (SWMC)
Mexico City children. MPAPs were significantly
correlated with ET-1 levels (r = 0.43, p = 0.0001). A
linear regression ﬁt to the data is shown. 
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Polotitlán
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SWMCUnder these environmental conditions, chil-
dren living in the city are most likely to be
exposed to high doses of air pollutants. On
school days, they spend signiﬁcant amounts of
time outdoors (3.94 ± 1 hr/day in this study),
both during school exercise periods and after
school (Villarreal-Calderón et al. 2002). On
weekends the outdoor play time is even
longer. This outdoor activity usually occurs
during hours when air pollutant levels are near
or exceed the standards. Healthy adult
humans exposed to concentrated ambient
PM2.5 and O3 experienced a significant
brachial artery vasoconstriction (Brook et al.
2002), whereas exposure to PM2.5 alone ele-
vated circulating ET-1 and ET-3 levels
(Vincent et al. 2001b). Compared with adults,
infants and children have much higher levels
of plasma ET-1. Moreover, the number of
ET-1 speciﬁc binding sites in infant’s and chil-
dren’s hearts (both atria and ventricles) has
been found to be signiﬁcantly higher than in
adults implying an enhanced physiologic func-
tion (Giannessi et al. 1999). Our data show
that clinically healthy children living in
Mexico City had increased concentrations of
circulating ET-1 and MPAP and that ET-1
levels were positively correlated with daily out-
door hours (p = 0.012), and 7-day cumulative
levels of PM2.5 (p = 0.03) before ET-1 mea-
surement. These ﬁndings are consistent with
controlled laboratory exposures of humans to
air pollutants. 
Several animal studies have reported
increased levels of ET-1 after exposure to air
pollutants (Bouthillier et al. 1998; Kang et al.
2002; Thomson et al. 2004, 2005; Vincent
et al. 2001a). Inhaled O3 and urban particles
have distinct toxicodynamics in rats with
respect to regulation of lung preproET-1 and
alteration of circulating ET-1 peptide levels.
Whereas O3 causes a rapid response, detected
immediately after exposure and subsiding
within 24 hr, urban particles cause a more
progressive and sustained response, with peak
increase of plasma ET-1 24–36 hr after expo-
sure (Thomson et al. 2005; Vincent et al.
2001a). The apparent predominant effect of
PM2.5 on ET-1 in the present study is in
keeping with these observations. 
The lungs are the primary source of circu-
lating endothelins, including ET-1. Mature
endothelins have a half-life on the order of
minutes due to rapid clearance from the blood-
stream through binding to G-protein-coupled
endothelin B (ETB) receptors in caveolae on
the surface of lung capillary endothelial cells
(Yamaguchi et al. 2003). Previous studies sug-
gest that there are at least three mechanisms
by which air pollutants could cause an
increase in ET-1 levels. First, both O3 and
PM can generate reactive oxygen species in
tissues, a condition that has been linked to
enhanced ET-1 expression (Kaehler et al.
2002). Second, ultrafine PM taken up by
endothelial cell caveolae, as described in north-
east Mexico City dogs (Calderón-Garcidueñas
et al. 2001b), may directly interfere with bind-
ing of ET-1 to ETB receptors, resulting in an
increase in the half-life of circulating ET-1.
Third, PM-associated LPS may increase
preproET-1 mRNA transcription and stability.
Douthwaite et al. (2003) exposed bovine aortic
endothelial cells to LPS and found a concentra-
tion-dependent ET-1 release that was associated
with increased transcription of preproET-1
mRNA and a 2-fold increase in preproET-1
mRNA half-life. This link between induction
of ET-1 synthesis and LPS exposure ought to
be considered in populations exposed to LPS,
both in environmental and occupational set-
tings. Environmental LPS is ubiquitous, so
everyone is exposed to this biological pollutant.
Mexico City has a variety of sources of environ-
mental LPS (e.g., open ﬁeld waste, waste dis-
posal dust, wastewater treatment plants, open
sewer channels, and daily outdoor deposits of
thousands of pounds of animal and human
fecal material) that contribute to measurable
levels of LPS in Mexico City PM10 (Osornio-
Vargas et al. 2003) and chronic exposure of
Mexico City residents to LPS. Although the
studies cited above present several plausible
mechanisms by which chronic exposure to the
complex mixture of air pollutants could induce
sustained increases in plasma ET-1 concentra-
tions, the extent of involvement of these mech-
anisms in humans remains to be determined. 
The consequences of sustained elevations
of ET-1 levels have been explored in animal
Air pollution and endothelin-1
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Figure 4. Scatterplots of complete blood count data by region. WBC, white blood cell. (A) Mean absolute
neutrophil counts were significantly lower in Mexico City children (n = 56) than in control children
(Polotitlán, n = 22). Northeast Mexico City children (NEMC, n = 17) had signiﬁcantly lower neutrophil counts
than control children (Polotitlán, n = 22). (B) The mean concentration of lymphocytes as a percentage of
white blood cells was signiﬁcantly higher in northeast Mexico City children (NEMC, n = 17) than in controls.
(C) Monocyte concentrations were similar in northeast (NEMC, n = 17) and southwest (SWMC, n = 39)
Mexico City and control (Polotitlán, n = 22) children. (D) White blood cell concentrations were not signiﬁ-
cantly different among Mexico City children (n = 59), Polotitlán children (n = 22), northeast (NEMC, n = 19)
and southwest (SWMC, n = 40) Mexico City children. Horizontal bar indicates group means. 
*p < 0.05.
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Figure 5. Estimated cumulative dose of PM2.5 (A), PM10 (B), and O3 (C) for northeast (NEMC) and southwest
(SWMC) Mexico City averaged (± SE) over the 1-, 2-, and 7-day periods before measurement of ET-1 lev-
els. The average dose calculations were based on estimates for each participating child. There were sig-
niﬁcant differences between the regions in the 1-, 2-, and 7-day cumulative PM2.5 dose and in the 2-day
and 7-day cumulative O3 dose. 
*p < 0.05; #p < 0.001.
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Cumulative time (days)models. Chronic expression of ET-1 in the
lungs of ET-1 transgenic mice causes progres-
sive pulmonary fibrosis and recruitment of
inﬂammatory cells, predominantly CD4-posi-
tive cells (Hocher et al. 2000). Chronic perfu-
sion of ET-1 in rats after 7 days increases
pulmonary vascular resistance, an effect that
disappears after 28 days of infusion possibly
because of compensatory mechanisms
(Migneault et al. 2005). In the same work,
Migneault et al. (2005) demonstrated that
chronic perfusion of ET-1 reduces the pul-
monary vasodilator reserve in response to
nitric oxide. The authors hypothesized that
an ET-1–induced increase of reactive oxygen
species production in both endothelial and
smooth muscle cells contributes to a reduc-
tion in the bioavailability of nitric oxide
(Migneault et al. 2005). 
Acute exposure to air pollutants such as
O3 and PM (especially ﬁne and ultraﬁne PM)
produces significant lung inflammation and
injury that involves both epithelial and
endothelial cells. Exposure to PM is also asso-
ciated with a systemic inﬂammatory response
that involves increased circulating levels of
inflammatory mediators that can activate
endothelium. Mexico City dogs exhibit focal
peribronchiolar inflammatory infiltrates that
surround the adjacent blood vessels, some of
which contain platelet thrombi and mar-
ginated neutrophils (Calderón-Garcidueñas
et al. 2001b). Moreover, pulmonary endothe-
lial cells in these dogs contain free ultrafine
PM in their cytoplasm, a situation that likely
promotes the production of free radicals and
endothelial damage (Calderón-Garcidueñas
et al. 2001a). Children in Mexico City have
fragmented red blood cells in peripheral
blood smears, also suggestive of endothelial
injury, most likely in the lung, because
microthrombi are numerous in small vessels
in the lungs of Mexico City dogs (Calderón-
Garcidueñas et al. 2001a, 2001b). Moreover,
ET-1 stimulates integrin-dependent adhesion
of neutrophil granulocytes to endothelial cells
(López et al. 1993), which could explain the
decreases in the concentration and total num-
ber of circulating neutrophils in Mexico City
children seen in this study. This notion is
supported by analysis of lung tissue from
healthy accidental-death victims from Mexico
City showing neutrophils attached to dam-
aged capillary endothelial cells (Calderón-
Garcidueñas et al. 2007). Taken together, this
evidence supports the notion that the sys-
temic increase in ET-1 in Mexico City chil-
dren could be a consequence of endothelial
damage and dysfunction. Endothelial dys-
function is characterized by a shift in the
actions of the endothelium toward reduced
vasodilatation, a proinflammatory state, and
prothrombic activities (Endemann and
Schiffrin 2004). Endothelial dysfunction
leads to chronic overproduction of vasocon-
strictors such as ET-1 (Humbert et al. 2004).
It is noteworthy that all the children from
northeast Mexico City in our study had
plasma ET-1 levels that were above the con-
trol mean. Of 19 subjects from the northeast,
14 had ET-1 values higher than all controls.
These data indicate that endothelial dysfunc-
tion and activation of the endothelin system
in response to air pollutant exposure, given a
sufficient PM dose, is a generalized effect
rather than being restricted to a subset of sen-
sitive individuals. This generalized effect for
an environmental exposure to pollutants is in
line with preliminary data from human sub-
jects exposed to concentrated urban ﬁne par-
ticles (Vincent et al. 2001b).
Mean pulmonary arterial pressures were
elevated on average in Mexico City children,
and the pressures correlated with ET-1 levels,
as might be expected given the pulmonary
vasoconstrictor effects of ET-1 and the
repeated observations of increased circulating
ET-1 in patients with elevated pulmonary
arterial pressure (Fratz et al. 2003; Galie et al.
2004; Mathew et al. 2004). Three of the
Mexico City children had MPAP levels at rest
> 25 mmHg, a characteristic of pulmonary
arterial hypertension (PAH). All children had
a negative family history of PAH, no known
risk factors for any disease that can cause
PAH (Simonneau et al. 2004), and no other
clinical symptoms of PAH. It is unclear at
this point whether these and perhaps other
Mexico City children will go on to develop
PAH. Both adults and children living at high
altitude, as all of our study subjects do, have a
higher prevalence of elevated MPAP and are
more prone to developing PAH. ET-1 over-
production is a plausible contributor to the
pathogenesis of PAH (Galie et al. 2004), and
pulmonary vasoconstriction is a likely early
component of PAH pathogenesis that can be
related to endothelial dysfunction (Humbert
et al. 2004). Taken together, these observa-
tions warrant additional studies that follow
Mexico City children for the development of
clinical symptoms of PAH as they grow older.
A prooxidative, dysfunctional endothe-
lium may contribute to a proatherogenic
environment through an inappropriate regu-
lation of vascular tone, permeability, coagula-
tion, fibrinolysis, and cell adhesion and
proliferation (Laight et al. 2000). Thus,
endothelial dysfunction is recognised as an
accessory in the pathogenesis of diabetic
macroangiopathy, obesity, hypertension, dys-
lipidemia, and in vivo insulin resistance
(Avogaro and De Kreutzenberg 2005; Laight
et al. 2000). Dong et al. (2004) have identi-
fied at least one allele of the ET-1 gene
(T1370G single nucleotide polymorphism)
that confers an increased risk of left ventricu-
lar hypertrophy in response to environmental
stress. Finally, ET-1 evokes cardiac mast cell
degranulation (Murray et al. 2004), which can
be arrhythmogenic. Indeed, extensive degranu-
lation of mast cells is observed in healthy
Mexico City dogs (Calderón-Garcidueñas et al.
2001a), and arrhythmias have been observed in
Mexico City children (Calderon-Garcidueñas
L, Hazucha MJ, Herbst MC, Reed W, Cascio
WE, unpublished data). Taken together, these
observations suggest that the elevated plasma
ET-1 levels observed in this study may fore-
shadow the development of clinical cardio-
pulmonary disease in Mexico City children. 
Conclusions
Chronic exposure of Mexico City children to a
complex mixture of air pollutants was associ-
ated with a signiﬁcant elevation of both plasma
ET-1 concentration and MPAP. The prospec-
tive health effects of sustained elevations of
plasma ET-1 and MPAP in growing children
are unknown. It is plausible that a chronic
exposure to signiﬁcant levels of air pollutants,
especially PM2.5, may lead to the development
of clinically signiﬁcant adverse health effects in
a subpopulation of Mexico City children later
in life. Our results clearly suggest a need for
epidemiologic and toxicologic studies that can
more fully characterize the association between
sustained ET-1 and MPAP elevations and the
development and progression of systemic
health effects in this population.
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